Misoprostol versus High Dose Oxytocin and Laminaria in Termination of Pregnancy in Second Trimester Pregnancies
Keywords:
Misoprostol; Laminaria, Oxytocin; Pregnancy terminationAbstract
Background: In 2 recent decades, found drug regimen to induce abortion that are more effective than surgery. prostaglandins especially misoprostol, oxytocin and osmotic dilators such as laminaria use for termination but the best method is unknown. Therefore we aimed to assess the comparison between the misoprostol regimen and the highly concentrated oxytocin with laminaria regimen in second trimester of pregnancy termination.
Methods: In this randomized clinical trial, 100 women with gestational age 14 to 24 week coming to hospital due to termination of pregnancy in the absence of uterine contractions and items of exclusion criteria enrolled to study and randomly assign to 2 groups and received misoprostol (group 1) or oxytocin (group 2). Data collected with use of observation, examination and demographic checklist. In group 1, in admission time and then every 6 hour patients received 200µgr misoprostol until start the pain or vaginal bleeding or abortion in 48 hr. in group 2, patients first received laminaria in cervix with duration of 6 hr and then oxytocin 50 unit in 500 cc normal saline in 3 hr. after 1 hr rest, oxytocin dosage elevated as multiple into 2 and continue until termination or maximum dose of 300 u in 500 cc normal saline. Data entered to SPSS software version 16 and analyzed with use of descriptive methods and also Chi-square and T-test.
Results: In each group enrolled 50 women that approximately no different in baseline characteristic. Number of abortion in misoprostol group was more than oxytocin group (P<0.001) and duration of abortion also was shorter than oxytocin in misoprostol group (P<0.001). Side effects in 23 (46%) women in misoprostol group were seen but no side effect seen in oxytocin group. Complementally interventions was seen in 31 women (60%) in misoprostol group versus 32 women (62%) in oxytocin group but this difference was not significant (P>0.05).
Conclusion: This study demonstrated that misoprostol is effective than oxytocin in termination of pregnancy but with attention to limitation of this study include of limited abortion causes due to legal laws, additional studies on different doses of misoprostol and oxytocin due to achieve to suitable regimen with lower side effects recommended.
References
Lin CJ, Chien SC, Chen CP. The use of misoprostol in termination of second-trimester pregnancy. Taiwanese journal of obstetrics & gynecology. 2011;50(3):275–82. Epub 2011/10/28. [PubMed] [Google Scholar]
Zangeneh M, Malek-Khosravi S, Veisi F, Rezavand N, Rezaee M, Rajatee M. Multiple-dose vaginal misoprostol and single-dose misoprostol plus oxytocin for termination of second-trimester pregnancy. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2012;117(1):78–80. Epub 2012/01/21. [PubMed] [Google Scholar]
Mentula MJ, Niinimaki M, Suhonen S, Hemminki E, Gissler M, Heikinheimo O. Immediate adverse events after second trimester medical termination of pregnancy: results of a nationwide registry study. Hum Reprod. 2011;26(4):927–32. Epub 2011/02/15. [PubMed] [Google Scholar]
van der Knoop BJ, Vandenberghe G, Bolte AC, Go AT. Placental retention in late first and second trimester pregnancy termination using misoprostol: a retrospective analysis. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2012;25(8):1287–91. Epub 2011/10/18. [PubMed] [Google Scholar]
Syed S, Noreen H, Kahloon LE, Chaudhri R. Uterine rupture associated with the use of intra-vaginal misoprostol during second-trimester pregnancy termination. JPMA The Journal of the Pakistan Medical Association. 2011;61(4):399–401. Epub 2011/04/07. [PubMed] [Google Scholar]
Cuellar Torriente M. Silent uterine rupture with the use of misoprostol for second trimester termination of pregnancy : a case report. Obstetrics and gynecology international. 2011;2011:584652. Epub 2011/07/19. [PMC free article] [PubMed] [Google Scholar]
Morotti M, Podesta S, Musizzano Y, Venturini PL, Bentivoglio G, Fulcheri E, et al. Defective placental adhesion in voluntary termination of second-trimester pregnancy and risk of recurrence in subsequent pregnancies. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2012;25(4):339–42. Epub 2011/05/26. [PubMed] [Google Scholar]
Murphy LA, Thornburg LL, Glantz JC, Wasserman EC, Stanwood NL, Betstadt SJ. Complications of surgical termination of second-trimester pregnancy in obese versus nonobese women. Contraception. 2012 Epub 2012/03/27. [PubMed] [Google Scholar]
Mentula M, Heikinheimo O. Risk factors of surgical evacuation following second-trimester medical termination of pregnancy. Contraception. 2012;86(2):141–6. Epub 2012/01/14. [PubMed] [Google Scholar]
Wagner N, Abele H, Hoopmann M, Grischke EM, Blumenstock G, Wallwiener D, et al. Factors influencing the duration of late first and second-trimester termination of pregnancy with prostaglandin derivates. European journal of obstetrics, gynecology, and reproductive biology. 2011;155(1):75–8. Epub 2010/11/30. [PubMed] [Google Scholar]
Kunwar S, Saha PK, Goel P, Huria A, Tandon R, Sehgal A. Second trimester pregnancy termination with 400 mug vaginal misoprostol: efficacy and safety. Bioscience trends. 2010;4(6):351–4. Epub 2011/01/21. [PubMed] [Google Scholar]
Ozerkan K, Ocakoglu G, Rehimli S, Uncu G, Develioglu O. A comparison of low-dose and high-dose protocols of vaginal misoprostol for second trimester termination of pregnancy. Clinical and experimental obstetrics & gynecology. 2009;36(4):245–7. Epub 2010/01/28. [PubMed] [Google Scholar]
Tanha FD, Golgachi T, Niroomand N, Ghajarzadeh M, Nasr R. Sublingual versus vaginal misoprostol for second trimester termination: a randomized clinical trial. Archives of gynecology and obstetrics. 2012 Epub 2012/08/21. [PubMed] [Google Scholar]
Cabrera Y, Fernandez-Guisasola J, Lobo P, Gamir S, Alvarez J. Comparison of sublingual versus vaginal misoprostol for second-trimester pregnancy termination: a meta-analysis. The Australian & New Zealand journal of obstetrics & gynaecology. 2011;51(2):158–65. Epub 2011/04/07. [PubMed] [Google Scholar]
Pongsatha S, Tongsong T. Randomized controlled study comparing misoprostol moistened with normal saline and with acetic acid for second-trimester pregnancy termination. Is it different? The journal of obstetrics and gynaecology research. 2011;37(7):882–6. Epub 2011/03/18. [PubMed] [Google Scholar]
Chaudhuri S, Banerjee PK, Mundle M, Mitra SN. A comparison of two regimens of misoprostol for second trimester medical termination of pregnancy: a randomized trial. Tropical doctor. 2010;40(3):144–8. Epub 2010/06/18. [PubMed] [Google Scholar]
Brouns JF, van Wely M, Burger MP, van Wijngaarden WJ. Comparison of two dose regimens of misoprostol for second-trimester pregnancy termination. Contraception. 2010;82(3):266–75. Epub 2010/08/14. [PubMed] [Google Scholar]
Pongsatha S, Tongsong T. Randomized comparison of dry tablet insertion versus gel form of vaginal misoprostol for second trimester pregnancy termination. The journal of obstetrics and gynaecology research. 2008;34(2):199–203. Epub 2008/04/17. [PubMed] [Google Scholar]
Zhuang Y, Chen X, Huang L. Mifepristone may shorten the induction-to-abortion time for termination of second-trimester pregnancies by ethacridine lactate. Contraception. 2012;85(2):211–4. Epub 2011/11/10. [PubMed] [Google Scholar]
Hou SP, Fang AH, Chen QF, Huang YM, Chen OJ, Cheng LN. Termination of second-trimester pregnancy by mifepristone combined with misoprostol versus intra-amniotic injection of ethacridine lactate (Rivanol(R)): a systematic review of Chinese trials. Contraception. 2011;84(3):214–23. Epub 2011/08/17. [PubMed] [Google Scholar]
Hou S, Chen Q, Zhang L, Fang A, Cheng L. Mifepristone combined with misoprostol versus intra-amniotic injection of ethacridine lactate for the termination of second trimester pregnancy: a prospective, open-label, randomized clinical trial. European journal of obstetrics, gynecology, and reproductive biology. 2010;151(2):149–53. Epub 2010/05/04. [PubMed] [Google Scholar]
Kelekci S, Erdemoglu E, Inan I. Randomized study on the effect of adding oxytocin to ethacridine lactate or misoprostol for second-trimester termination of pregnancy. Acta obstetricia et gynecologica Scandinavica. 2006;85(7):825–9. Epub 2006/07/04. [PubMed] [Google Scholar]
Pongsatha S, Tongsong T. How to manage unresponsiveness to misoprostol in failed second trimester pregnancy termination. The journal of obstetrics and gynaecology research. 2012 Epub 2012/06/14. [PubMed] [Google Scholar]
Kent A. Second trimester termination of pregnancy. Reviews in obstetrics and gynecology. 2011;4(2):95. Epub 2011/11/22. [PMC free article] [PubMed] [Google Scholar]
Naguib AH, Morsi HM, Borg TF, Fayed ST, Hemeda HM. Vaginal misoprostol for second-trimester pregnancy termination after one previous cesarean delivery. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2010;108(1):48–51. Epub 2009/09/29. [PubMed] [Google Scholar]
Ramin KD, Ogburn PL, Danilenko DR, Ramsey PS. High-Dose Oral Misoprostol for Mid-Trimester Pregnancy Interruption. Obstet Invest. 2002;54(3):176–179. [PubMed] [Google Scholar]
Owen J, Hauth JC. “Vaginal misoprostol vs. concentrated oxytocin plus low-dose prostaglandin E2 for second trimester pregnancy termination” J Matern Fetal Med. 1999;8(2):48–50. [PubMed] [Google Scholar]
Zangeneh M, Malek-Khosravi S, et al. “Multiple-dose vaginal misoprostol and single-dose misoprostol plus oxytocin for termination of second-trimester pregnancy” Int J Gynaecol Obstet. 2012;117(1):78–80. [PubMed] [Google Scholar]
Almog B, Levin I, Winkler N, Fainaru O, Pauzner D, Lessing JB, et al. The contribution of laminaria placement for cervical ripening in second trimester termination of pregnancy induced by intra-amniotic injection of prostaglandin F(2)alpha followed by concentrated oxytocin infusion. European journal of obstetrics, gynecology, and reproductive biology. 2005;118(1):32–5. Epub 2004/12/15. [PubMed] [Google Scholar]
Published
Issue
Section
License
Copyright (c) 2020 Knowledge Kingdom Publishing
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
